Clinical Trials Directory

Trials / Unknown

UnknownNCT01554202

Multi-modal Neuroimaging in Alzheimer's Disease

Study of the Predictive Markers and the Pathophysiological Mechanisms of Alzheimer's Disease: Transverse and Longitudinal Approach in Anatomical and Functional Multimodal Imaging

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
295 (estimated)
Sponsor
University Hospital, Caen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

According to estimations, Alzheimer's disease affects approximately 860,000 people aged of more than 65 years in France. This disease is characterized by disorders of cognitive functions, including memory, associated with structural and functional modifications of the brain. These changes are evolving within the pathology progression and can be evaluated with neuropsychological tests (to assess capabilities such as language, orientation, etc.) and also with brain imaging (e.g. MRI). Alzheimer's disease is still poorly understood, nevertheless currently available treatments can slow its development if the disease is diagnosed early enough. Thus, the objective is to identify markers for early diagnosis of Alzheimer's disease, to better describe the evolution of this disease. The three main objectives of this project are * to identify, compare and combine predictive markers of Alzheimer's disease * to make a significant contribution to the understanding of the pathophysiological mechanisms of Alzheimer's disease * to study the ability of different neuroimaging techniques to follow the evolution of this pathology.

Conditions

Interventions

TypeNameDescription
BEHAVIORALassessment of memory
BIOLOGICALcirculating tPA dosage
GENETICApoE4
OTHERBrain imaging examination MRI and PET examinations

Timeline

Start date
2008-01-01
Primary completion
2021-12-01
First posted
2012-03-14
Last updated
2013-03-06

Locations

5 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01554202. Inclusion in this directory is not an endorsement.